CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement
- 8-K Event Delisting notice
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 3 Insider Initial Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 25,449 shares at $0.37 ($9,531)
- 4 Open-market buy General Counsel & VP of BD bought 8,200 shares at $0.36 ($2,911)
- 4 Open-market buy Director bought 56,000 shares at $0.31 ($17,629)
- 4 Open-market buy President and CEO bought 11,200 shares at an average $0.31 ($3,424)
Page 36 of 74 · 1,465 filings